Efficacy of interleukin-1 blockade in Schnitzler’s syndrome without detectable monoclonal gammopathy: a case-based review
Open Access
- 11 November 2020
- journal article
- review article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 40 (7) , 2973-2977
Abstract
Schnitzler’s syndrome (SchS) is a rare autoinflammatory disorder characterized by urticarial rash and monoclonal gammopathy which is currently regarded as IL-1 mediated disease. We present the case of a 21-year-old woman presenting with urticarial rash, arthralgias, and elevated inflammatory markers. She has been suffering these symptoms for 2 years and was treated with antihistamines, omalizumab, steroids, and non-steroidal anti-inflammatory drugs (NSAIDs) without success. After an extensive diagnostic workout, we suspected SchS even without monoclonal gammopathy, and started Anakinra 100 mg daily with a dramatic response and achieving complete remission after 48 h of the beginning of the treatment, so we decided to confirm SchS diagnosis. We performed a search of the literature and found seven more cases of patients diagnosed with SchS without monoclonal gammopathy at the presentation. Five were treated with IL-1 blocking therapies and all achieved remission. We, therefore, prompt the possible role of IL-1 blockade therapy remission as support in diagnosing SchS without monoclonal gammopathy.Keywords
Funding Information
- Università degli Studi di Verona
This publication has 16 references indexed in Scilit:
- Schnitzler Syndrome Without a Monoclonal GammopathyJournal of Cutaneous Medicine and Surgery, 2016
- The role of interleukin-1 beta in the pathophysiology of Schnitzler’s syndromeArthritis Research & Therapy, 2015
- Delayed development of the IgM paraprotein in Schnitzler’s syndromeScandinavian Journal of Rheumatology, 2015
- Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: A french multicenter studyAutoimmunity Reviews, 2014
- Schnitzler's syndrome: lessons from 281 casesClinical and Translational Allergy, 2014
- Schnitzler syndrome: an under-diagnosed clinical entityHaematologica, 2013
- Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler’s syndrome: a case report and literature reviewClinical Rheumatology, 2010
- Schnitzler's Syndrome without Monoclonal GammopathyActa Dermato-Venereologica, 2005
- Severe course of chronic urticaria, arthralgia, fever and elevation of erythrocyte sedimentation rate: Schnitzler’s syndrome without monoclonal gammopathy?British Journal of Dermatology, 2000
- Penicillamine-induced elastosis perforans serpiginosa and cutis laxa in Wilson’s diseaseBritish Journal of Dermatology, 2000